Was fortunate to get heavily involved with this at Argonaut whilst I was there. The 2c RTO was one of the least greedy vends I have seen in my career. Everything is going to plan, and I must say that Callahan is one of the most proactive (pun intended) CEO's I have dealt with in 20 years. In fact I was saying to the guys, that BOT are so good at IR and keeping the market informed that the lack of surprises may be holding them back. The timelines are also well set out, however the real re-rating could come from something totally unexpected.
I have sat through the presentations, tried Permatrex on my own skin (it does get in), and remain confident that as the trials progress Callahan must be getting closer to major Pharma interest.
Selling was unfortunate but came from weak hands that shouldn't have held the stock in the first place.
Who knows maybe they could spin out Callahan's frequent flyer points, the guy just doesn't stop.
BOT Announce Successful Phase 1 Study for BTX1503, page-59
-
- There are more pages in this discussion • 2 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add BOT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
40.0¢ |
Change
0.050(14.3%) |
Mkt cap ! $724.0M | |||
| Open | High | Low | Value | Volume |
| 35.5¢ | 40.0¢ | 35.5¢ | $6.075M | 15.87M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 5 | 287187 | 39.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 40.0¢ | 1920397 | 33 |
View Market Depth
| Last trade - 16.10pm 30/08/2024 (20 minute delay) ? |
| BOT (ASX) Chart |